首页 | 官方网站   微博 | 高级检索  
     

绝经期激素补充治疗对血清E2、血脂及子宫内膜的影响
引用本文:王永霞,曹茵.绝经期激素补充治疗对血清E2、血脂及子宫内膜的影响[J].赣南医学院学报,2004,24(4):378-380.
作者姓名:王永霞  曹茵
作者单位:广东东莞市人民医院,广东,东莞,511700
摘    要:目的观察不同绝经年限妇女激素补充治疗(HRT)对血清E2、血脂及子宫内膜的影响.方法对38例绝经1~5年和30例绝经5年以上妇女连续联合使用激素补充治疗半年,用药前后观察绝经期症状、血清E2、血脂四项、子宫内膜厚度及内膜细胞形态变化.结果用药后两组之绝经期症状均明显改善,Kupperman评分显著下降;用药后E2均显著升高(P<0.01),FSH显著下降(P<0.05);绝经1~5年组总胆固醇(CHOL)、甘油三酯(TG)、低密度脂蛋白(LDL)均显著下降,高密度脂蛋白(HDL)显著上升;而绝经5年以上组用药后CHOL、LDL有所下降,而TG、HDL有升高趋势,但差异无统计学意义.两组HRT后子宫内膜均较HRT前增厚,1~5年组以混合型及增殖期型比例为主,而5年以上组以萎缩型为主.内膜>5mm者,1~5年组以增殖期型及伴分泌象为主,而5年以上组以增殖期型为主.1~5年组非计划性出血率高于5年以上组.结论不同绝经年限妇女使用激素补充治疗(HRT)均能显著改善绝经期症状,但在血脂代谢及对子宫内膜的影响上却存在差异,使用HRT时宜根据绝经年限、治疗目的选择用药.

关 键 词:激素补充治疗  血脂  子宫内膜
文章编号:1001-5779(2004)04-0378-03
修稿时间:2004年7月12日

The Influence of Human Supplementary Menopausal Hormonotherapy on Serum E2,Blood-lipid and Endometrium
WANG Yong xia,CAO Ying.The Influence of Human Supplementary Menopausal Hormonotherapy on Serum E2,Blood-lipid and Endometrium[J].Journal of Gannan Medical College,2004,24(4):378-380.
Authors:WANG Yong xia  CAO Ying
Abstract:Objective:The influence of human supplementary menopausal hormonotherapy on serum E2,blood-lipid and endometrium of the women of different ages was observed.Methods:38 cases of menopause from one to five years and 30 cases of menopause for more than five years were used human supplementary menopausal hormonotherapy for half a year.Before and after the administration,the climacteric symptom,serum E2,the depth of endometrium as well as the changes of cell shape in tunica intima were observed.Results:After the administration,the climacteric symptom of the above two groups had been obviously improved.The Kupperman evaluation had been obviously decreased.E2 was significantly raised ( P <0.01) and FSH was significantly decreased ( P <0.05).Conclusion:The use of supplementary menopausal hormonotherapy at different menopauses can significantly improve the climacteric symptom,but as far as blood-lipid metabolism and the influence on endometrium are concerned,there exist differences.The use of supplementary menopausal hormonotherapy should be used according to the time of menopause and the purpose of treatment.
Keywords:supplementary hormonotherapy  serum  endometrium
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号